Filing Flows

Filing Flows › SkinHealth Systems (SKIN) › Q3 2025

SkinHealth Systems (SKIN) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 6, 2025

SkinHealth Systems (SKIN) reported revenue of $70.7M for the third quarter 2025 (Q3 2025), -10% from a year earlier and -10% from the quarter before. Operating margin was -8.8%, net loss $11.0M (15.6% of revenue).

Revenue$70.7M
Year over year-10%
Quarter over quarter-10%
Operating margin-8.8%
Net earnings−$11.0M

SkinHealth Systems, Q3 2025: revenue $70.7M (-10% year over year), operating margin -8.8%, net loss $11.0M, operating cash flow $9.6M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$70.7M-10%-10%
Operating profit−$6.2M——
Net earnings−$11.0M-156%—
Operating cash flow$9.6M0%-6%
Free cash flow$9.6M+0.7%-7%

What changed

Revenue was $70.7M in Q3 2025, down 10% year over year and down 10% from the previous quarter. Consumables was the largest line at 71% of revenue. Delivery Systems lost $6.8M year over year (down 25%), 83% of the total change.

Gross margin was 64.6%, up 13.0 points from a year earlier. Operating costs exceeded revenue by $6.2M, an operating margin of -8.8%. Operating expenses fell 17% while revenue fell 10%. The fastest-growing cost line was Research & development (+53%). The quarter ended with a net loss of $11.0M, after a profit of $19.7M the previous quarter.

Operating cash flow was $9.6M (down 6% year over year). Non-cash charges added back $7.3M of depreciation and amortization and $2.5M of share-based compensation. Working capital and other items added $10.9M. Capital expenditures of $27K left free cash flow of $9.6M.

Questions

What was SkinHealth Systems' revenue in the third quarter 2025?

SkinHealth Systems (SKIN) reported revenue of $70.7M for the third quarter 2025 (Q3 2025), -10% from a year earlier and -10% from the quarter before.

Was SkinHealth Systems profitable in the third quarter 2025?

Operating loss was $6.2M (-8.8% of revenue) and net loss $11.0M.

Open the interactive Sankey →

Source: SkinHealth Systems 10-Q on SEC EDGAR.